Cerebral venous sinus thrombosis in Behcet's disease: A case report

Journal of the Medical Association of Thailand

Volumn 87, Issue 7, 2004, Pages 845-849

  Limotai, Chusak ^a   Phanthumchinda, Kammant ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Behcet's disease; Cerebral venous sinus thrombosis

Indexed keywords

ANTICOAGULANT AGENT; CHLORAMBUCIL; PREDNISOLONE;

ABDUCENS NERVE PARALYSIS; ADULT; ARTICLE; BEHCET DISEASE; CASE REPORT; CEREBRAL SINUS THROMBOSIS; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; EMPTY SELLA SYNDROME; GENITAL ULCER; HEMIPARESIS; HUMAN; INFLAMMATORY DISEASE; INTERNAL JUGULAR VEIN; INTRACRANIAL HYPERTENSION; MALE; MOUTH ULCER; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE; PAPILLEDEMA; PHLEBOGRAPHY; PHYSICAL EXAMINATION; SKIN TEST; SUPERIOR SAGITTAL SINUS; TRANSIENT ISCHEMIC ATTACK; UVEITIS;

ADULT; BEHCET SYNDROME; CEREBRAL VEINS; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MAGNETIC RESONANCE IMAGING; MALE; RECURRENCE; VENOUS THROMBOSIS;

EID: 4444319599     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Bechet H. Über residivierende, aphtose, durch ein Virus verursachtes Geschwure am Mund, am Auge, und an der Genitalien. Derm Wschr 1937; 105: 1152-7.
2. Inaba G. Behcet's disease. In: Vinken PJ, Bruyn GW, Klawans HL, editors. Handbook of clinical neurology, Vol. 56. Amsterdam: Elsevier; 1989: 593-610.
3. International Study Group for Behcet's Disease. Criteria for diagnosis of Behçet's disease. [Review]. Lancet 1990; 335: 1078-80.
4. O'Neill TW, Rigby AS, McHugh S, Silman AJ, Barnes C, on behalf of the International Study Group For Behcet's disease. Regional differences in clinical manifestations of Behcet's disease. In: Wechsler B, Godeau P, editors. Behcet's disease. Amsterdam: Elsevier; 1993: 159-63.
5. Hamuryudan V, Mat C, Saip S, özyazgan Y, Siva A, Yurdakul S, et al. Thalidomide in the treatment of the mucocutaneous lesions of the Behcet's disease [see comments]. Ann Intern Med 1998: 128: 443-50. Comment in: Ann Intern Med 1998: 128: 494-5.
6. Hamuryudan V, Mat C, Saip S, özyazgan Y, Siva A, Yurdakul S, et al. Thalidomide in the treatment of the mucocutaneous lesions of the Behcet's disease [see comments]. Ann Intern Med 1998: 128: 443-50. Comment in: Ann Intern Med 1998: 128: 494-5.
7. Wolf SM, Schotland DL, Phillips LL. Involvement of nervous system in Behcet's syndrome. Arch Neurol 1965; 12: 315-25.
8. Bousser MG, Bletry O, Launay M, Portier E, Guillard A, Castaigne P. Thromboses veineuses cerebrales au cours de la maladie de Behcet. Rev Neurol (Paris) 1980; 136: 753-62.
9. El-Ramahi KM, al-Kawi MZ. Papilloedema in Behçet's disease; value of MRI in diagnosis of dural sinus thrombosis. J Neurol Neurosurg Psychiatry 1991; 54: 826-9.
10. Serdaroglu P. Behcet's disease and the nervous system. [Review]. J Neurol 1998; 245: 197-205.
11. Pallis CA, Fudge BJ. The neurological complications of Behcet's syndrome. Arch Neurol Psychiatry 1956; 75: 1-14.
12. Lakhanpal S, Tani K, Lie JT, Katoh K, Ishigatsubo Y, Ohokubo T. Pathologic features of Behcet's syndrome: a review of Japanese autopsy registry data. Hum Pathol 1985; 16: 790-5.
13. Yazici H, Yurdakul S, Hamuryudan V. Behcet's syndrome. Curr Opin Rheumatol 1999; 11: 53-7.
14. nd ed. London: Mosby, 1998: 7.26.1-7.26.6.
15. Main D, Chamberlain MA. Clinical differentiation of oral ulceration in Behcet's disease. Br J Rheumatol 1992; 31: 767-70.
16. Akman-Demir G, Serdaroglu P, Tasci Band the Neuro-Behcet Study Group. Clinical patterns of neurological involvement in Behcet's disease: Evaluation of 200 patients. Brain 1999; 122: 2171-81.
17. James DG. Silk route disease. Postgrad Med J 1986; 62: 151-3.
18. Daif A, Awada A, Al-Rajeh A, Abduljabbar M, Al Tahan A, Obeid T, et al. Cerebral venous thrombosis in adults: A study of 40 cases from Saudi Arabia. Stroke 1995; 26: 1193-5.
19. Phanthumchinda K, Wanichapol S, Thaipisuttikul I, Suwanwela NC. Aseptic cerebral venous thrombosis. A perspective study in a University in Thailand. Cerebrovasc Dis 2003; 16 (Suppl 4): 108.
20. Kocer N, Islak C, Siva A, Saip S, Akman C, Kantarci O, et al. CNS involvement in Neuro-Behcet syndrome: An MR study. Am J Neuroradiol 1999; 20: 1015-24.
21. Harris KC, Tran DD, Sickels WJ, Cornell SH, Yuh WTC. Diagnosing intracranial vasculitis: the roles of MRI and angiography. Am J Neuroradiol 1994; 15: 317-30.
22. Greenan TJ, Grossman RI, Goldberg HI. Cerebral vasculitis: MRI imaging and angiographic correlation. Radiology 1992; 182: 65-72.
23. Ohno S, Ohguchi M, Hirose S, Matsuda H, Wakisaka A, Aizawa M. Close association of HLA Bw51 in Behcet's disease. Arch Ophthalmol 1982; 100: 1455-8.
24. th International conference on Behcet's disease. Tunis: PUB ADHOUA, 1996: 173-6.
25. Yazici H, Tuzun Y, Pazarli H. Behcet's disease as seen in Turkey: Haematologica 1980; 65: 381-3.
26. th International conference on Behcet's disease. Tunis: PUB ADHOUA, 1996: 217-8.
27. Kaklamani V, Vaiopoulos G, Kaklamanis P. Behcet's disease. Semin Arthritis Rheum 1998; 27: 197-217.
28. Kontogiannis V, Powell RJ. Behcet's disease. Postgrad Med J 2000; 76: 629-37.
29. Aktulga A, Altac M, Muftuoglu A. A double blind study of colchicines in Behcet's disease. Haematologica 1980; 65: 399-402.
30. Jorizzo J, White W, Wise C, Zanolli M, Sherertz E. Low-dose weekly methotrexate for unusual neutrophilic vascular reactions: cutaneous polyarteritis nodosa and Behcet's syndrome. J Am Acad Dermatol 1991; 24: 973-8.
31. Akoglu T, Direskeneli H, Yazici H. TNF, soluble IL-2R and soluble CD-8 in Behcet's disease. J Rheumatol 1990; 17: 1107-8.
32. Hamuryudan V, Ozyazgan Y, Hizli N, Mat C, Yurdakul S, Tuzun Y, et al. Azathioprine in Behcet's syndrome: effects on long term prognosis. Arthritis Rheum 1997; 40: 769-74.
33. Binder A, Graham E, Sanders M, Dinning W, James D, Denman A, et al. Cyclosporin A in the treatment of severe Behcet's uveitis. Br J Rheumatol 1987; 26: 285-91.
34. Masuda K, Nakajima A, Urayama A, Nakae K, Kogure M, Inaba G. Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behcet's disease. Lancet 1957; 2: 353-8.
35. O'Duffy JD, Robertson DM, Goldstein NP. Chlorambucil in the treatment of uveitis and meningoencephalitis of Behcet's disease. Am J Med 1984; 76: 75-84.
36. Ozyzgan Y, Yurdakul S, Yazici H, Tuzun B, Iscimen A, Tuzun Y, et al. Low-dose cyclosporin A versus pulsed cyclophosphamide in Behcet's syndrome: a single masked trial. Br J Ophthalmol 1992; 76: 241-3.
37. Whitcup S, Salvo E, Nussenblatt RB. Combined cyclosporin and corticosteroid therapy for sight threatening uveitis in Behcet's disease. Am J Ophthalmol 1994; 118: 39-45.
38. th International congress on Behcet's disease (abstract). Reggio Emilia: Prex srl, 1998: 89.